中文名 | Bay 60-7550 |
英文名 | Bay 60-7550 |
英文别名 | BAY 607550 BAY 60-7550 Bay 60-7550 2-(3,4-Dimethoxybenzyl)-7-((2R,3R)-2-hydroxy-6-phenylhexan-3-yl)-5-methylimidazo[5,1-f][1,2,4] 2-[(3,4-Dimethoxyphenyl)methyl]-7-[(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl]-5-methyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[(3,4-dimethoxyphenyl)methyl]-7-[(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl]-5-methyl- |
CAS | 439083-90-6 |
化学式 | C27H32N4O4 |
分子量 | 476.57 |
密度 | 1.24±0.1 g/cm3(Predicted) |
沸点 | 680.7±65.0 °C(Predicted) |
酸度系数 | 14.54±0.20(Predicted) |
存储条件 | -20°C |
外观 | 粉末 |
颜色 | white to light brown |
体外研究 | Bay 60-7550 (1 μM) increases cGMP in the neuronal cultures compared with control [F(6,14)=12.97, p<0.05 for Bay 60-7550]. Bay 60-7550 in the presence of NMDA (30 μM) results in further increases in cGMP compared with NMDA alone. The NMDA receptor antagonist MK-801 (10 μM) blocks both Bay 60-7550+NMDA-induced elevation in cGMP in neuronal cultures. Compared with untreated control cells, proliferation of PASMCs from IPAH patients is significantly reduced by BAY 60-7550 (1 μM). |
体内研究 | The PDE2 inhibitors Bay 60-7550 (1 mg/kg) reverses restraint stress-induced alterations in behavior, resulting in increased percentages of open-arm entries and open-arm time compared with the vehicle + restraint stress condition. In nonstressed mice, Bay 60-7550 produces a dose-dependent increase in percentages of open-arm entries and open-arm time compared with the vehicle-treated group; significant increases are observed at a dose of 3 mg/kg. In nonstressed mice, Bay 60-7550 increases, in a dose-dependent manner, the number of head-dips and time spent head-dipping, compared with vehicle-treated mice; significant increases are observed at doses of 1 and 3 mg/kg. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.098 ml | 10.492 ml | 20.983 ml |
5 mM | 0.42 ml | 2.098 ml | 4.197 ml |
10 mM | 0.21 ml | 1.049 ml | 2.098 ml |
5 mM | 0.042 ml | 0.21 ml | 0.42 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!